NEW YORK (GenomeWeb News) – High-speed biomedical imaging company Cyntellect said today that it is collaborating with the Burnham Institute for Medical Research to develop new applications for the company’s in situ cellular imaging tool.
The San Diego-based company said the agreement gives the Burnham researchers access to its LEAP cell imaging and laser processing platform, while Cyntellect gains commercial rights to certain discoveries produced by the collaboration.
The LEAP live cell analysis and processing system incorporates high-speed optical imaging with image analysis and laser cell manipulation, which can be used in cell cloning, image-based cell purification of adherent and non-adherent cell types, and laser-based macromolecule delivery into cells, including siRNA, small molecules, proteins, and quantum dots.
Cyntellect said it expects that the new applications it develops through the collaboration can be used to understand stem cell differentiation factors and pathways and to generate cell populations that could be used as stem cell therapeutics.